LAB Q3 2017 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$370M

Q3 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$25M+11.5% YoY

Gross Profit

$12M49.2% margin

Operating Income

-$16M-63.0% margin

Net Income

-$16M-64.4% margin

EPS (Diluted)

$-0.46

QoQ Revenue Growth

+3.5%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$9M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$292M

Total Liabilities

$253M

Stockholders' Equity

$39M

Cash & Equivalents

$61M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$25M	$22M	+11.5%
Gross Profit	$12M	$12M	+2.4%
Operating Income	-$16M	-$18M	+15.6%
Net Income	-$16M	-$20M	+19.4%

Geographic Segments

UNITED STATES

$11M45%

Europe

$8M31%

Asia Pacific

$5M20%

Other Geographical Countries

$1M4%